Olema Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +9.6% | +21.8% | +15,018.2% | -0.3% | -77.3% | +4.2% | – | |
| – | – | – | – | – | – | – | – | |
| – | +131.5% | +249.6% | +272.9% | +61.0% | +4.7% | +44.6% | +26.6% | |
| – | +4.4% | +1,841.4% | +160.6% | +21.2% | -23.8% | -5.7% | +18.4% | |
| – | +107.9% | +397.7% | +232.3% | +49.7% | -1.9% | +35.5% | +25.6% | |
| – | – | – | – | – | – | – | – | |
| – | -100.0% | – | -64.5% | +53.9% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | -132.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.